MINNEAPOLIS/PRNewswire/ — Nonin Medical, Inc. announced today
the U.S.
market release of its EQUANOX™ Advance Model 8004CB Series neonatal/pediatric sensor.
The EQUANOX Advance 8004CB Series Sensor with Nonin’s patent-pending Dynamic Compensation™
algorithm is the first and only cerebral/somatic sensor to automatically account
for pediatric brain-tissue-development variation when measuring oxygen saturation
levels. The sensors are designed for use with Nonin’s EQUANOX™ Advance Model 7600
Oximetry System in cerebral or somatic positions on patients weighing less than
40 kg.
EQUANOX is a near infra-red spectroscopy (NIRS)-based monitoring
device that noninvasively and continuously detects oxygen saturation status in brain
and other tissue. The device allows clinicians to quickly react to reverse harmful
tissue ischemia events before they become critical.
“Nonin Medical is pleased to announce this latest advancement
in tissue oxygen saturation monitoring for neonatal and pediatric patients,”
said Kevin McGowan, Vice President-Global Sales for Nonin Medical. “Until now,
pediatric cerebral/somatic oximetry sensors have essentially been trimmed versions
of adult sensors. Nonin’s 8004CB Sensor is designed specifically for pediatric patients.
The sensor features adhesive and non-adhesive versions for delicate skin, a small
footprint for space-saving placement, short light-path spacing for pediatric-appropriate
tissue-depth readings, and Nonin’s Dynamic Compensation™ algorithm for calculating
accurate, patient-specific values. And because the 8004CB provides a single-sensor
solution for all patients less than 40 kg, it simplifies protocols and inventory
requirements, saving time and money.”
“Nonin’s EQUANOX™ Advance 8004CB sensor represents a major
step forward in pediatric patient monitoring because it provides absolute, real-time
accuracy of cerebral oxygenation status without requiring the physician to input
patient demographics or stock and choose from multiple sensors,” said Dr. Dean
Kurth, Anesthesiologist-in-Chief for Cincinnati Children’s Hospital Medical
Center.
“The problem is, light attenuation of pediatric brain tissue
changes with age and varies from patient to patient, which can impact traditional
cerebral oximetry systems,” Kurth said. “To compensate for this, some
pediatric oximetry systems require physicians to choose from different sensor sizes
or enter the patient’s age or weight to obtain accurate rSO2 measurements. Nonin’s
new 8004CB Sensor, with its Dynamic Compensation algorithm, is the first sensor
to automatically adjust for pediatric brain myelination changes. So now physicians
have a single-sensor solution that provides oxygen saturation readings based on
the child’s true physiology.”
The EQUANOX Advance 8004CB and 8004CB-NA (non-adhesive) Neonatal/Pediatric
Sensors, along with the Model 7600 Oximetry System, provide additional advantages
including:
- Cerebral and Somatic Monitoring – Up to four channels displayed
on one screen for monitoring oxygen saturation in the brain and somatic sites on
the body, including kidney and liver sites - Patented Dual-Light Emitters and Detectors with Four Wavelength
Accuracy – The first and only device that utilizes a dual-light emitting and detecting
sensor architecture, which has been shown to more effectively target the cerebral
cortex, eliminating surface artifacts that interfere with measurement accuracy(1) - Absolute Accuracy – Assures accurate measure of tissue saturation
at a point in time, not just relative or trending accuracy of changes - Consistency and Reliability – Rapid, reliable response to change
without signal instability and interruptions from ambient electrical and light interferences - Portability and Connectivity – Lightweight, durable monitor with
long battery life and pole-mounting capability for continually monitoring patients
during intra-hospital transport. Data output available via Bluetooth® wireless technology
or RS232 connection. Interfaces with Philips® VueLink (through Philips IntelliVue®
Monitor), Philips CompuRecord Anesthesia Information System, Spectrum Medical VIPER
Independent Data Management System and Sorin Perfusion Data Management System.
Contact Nonin Medical at 1.800.356.8874 or visit www.noninequanox.com
for more information or to schedule an on-site evaluation.
About Nonin Medical, leaders in noninvasive medical monitoring
Nonin Medical, Inc. invented finger pulse oximetry and designs and manufactures
innovative, noninvasive medical monitoring solutions to meet customers’ technology
needs today and tomorrow. Headquartered in Minneapolis,
Minn. with an additional service center in Hudiksvall, Sweden,
Nonin Medical sells its pulse and regional oximeters, capnographs, sensors and software
to health professionals and consumers in more than 125 countries. The company also
has more than 100 OEM partners worldwide. For more information, visit www.nonin.com.
(1) Davie
SN, Grocott HP. Impact of Extracranial Contamination on Regional Cerebral Oxygen
Saturation: A Comparison of Three Cerebral Oximetry Technologies. Anesthesiology.
2012; 116(4):1-7.